Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1Glioma 1Extensive Stage Lung Small Cell Carcinoma 1

Interventions

atezolizumab 4Specimen Handling 2Magnetic Resonance Spectroscopy 2Etoposide 2Carboplatin 2talazoparib 1lipoarabinomannan 1Radiotherapy 1Radiation 1Lamivudine 1LB100 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Extensive Stage Lung Small Cell Carcinoma × Lamivudine × 1 year × Clear all
NCT04696575 2025-12-15

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 2 Recruiting
28 enrolled

Extensive Stage Lung Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡